Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Altevogt

Peter Altevogt, Neckargemund DE

Patent application numberDescriptionPublished
20100279315IMPROVED METHOD FOR PRENATAL DIAGNOSIS - The invention discloses a method of prenatal diagnosis comprising the step of isolating exosomes from an isolated fluid, wherein the exosomes are identified by biomarker detection. Furthermore, the invention discloses the isolation of exosomes from an isolated fluid and the use of a biomarker, particularly CD24 to isolate exosomes from an isolated fluid.11-04-2010

Peter Altevogt, Ettlingen DE

Patent application numberDescriptionPublished
20100217761System and Method of Enhancing Decoding Performance of Text Indexes - The present invention provides a system for enhancing the decoding performance of text indexes of an indexed collection of text documents. The posting list includes a plurality of list entries being of variable size depending on the value stored in each posting list entry. The inventive system is based on a statistical analysis of the posting list entries of the plurality of list entries. Prior to decoding, the system can select a decoding procedure being appropriate to decode the most frequent type of posting list entries or of a plurality of various posting list entries. After selecting a particular decoding procedure and executing the decoding procedure for decoding of the entire posting list, a failure check is performed. In the exceptional case that a failure has occurred, a second alternative decoding procedure is selected and executed.08-26-2010

Patent applications by Peter Altevogt, Ettlingen DE

Peter Altevogt, Nekargemund DE

Patent application numberDescriptionPublished
20090162355TREATMENT OF TUMORS USING SPECIFIC ANTI-L1 ANTIBODY - The present invention relates to the anti-L1 monoclonal antibody 9.3 as well as to related antibodies or binding molecules and well as to the uses thereof, especially in tumor treatment.06-25-2009

Peter Altevogt, Neckardgemund DE

Patent application numberDescriptionPublished
20080299123TREATMENT OF CHEMOTHERAPY- OR RADIOTHERAPY-RESISTANT TUMORS - The present invention relates to the use of L1 interfering molecules, especially anti-L1 antibodies, in tumor treatment. Especially, the present invention relates to the use of said L1 interfering molecules in sensitizing tumor cells for the treatment with chemotherapeutic drugs of with radiotherapy and to the combined administration of L1 interfering molecules with chemotherapeutic drugs or with radiotherapy.12-04-2008